Uterine natural killer cells: from foe to friend in reproduction.
Autores de IIS La Fe
Grupos
Abstract
Recurrent miscarriage and pre-eclampsia are common reproductive disorders, but their causes are often unknown. Recent evidence has provided new insight into immune system influences in reproductive disorders. A subset of lymphocytes of the innate immune system known as uterine natural killer (uNK) cells are now recognized as fundamental to achieving embryo implantation and successful pregnancy, but were initially attributed a bad reputation. Indeed, immune therapies have been developed to treat the 'exaggerated' immune response from uNK cells. These treatments have been based on studies of peripheral blood natural killer (pbNK) cells. However, uNK cells and pbNK cells have different phenotypic and functional characteristics. The functions of uNK cells are closely related to their interactions with the extravillous trophoblast cells (EVTs) and spiral arteries, which underlie an essential role in regulating vascular function, controlling trophoblast invasion and promoting placental development. EVTs express MHC molecules of class I HLA-C/E/G/F, while uNK cells express, among other receptors, killer cell immunoglobulin-like receptors (KIRs) that bind to HLA-C or CD94/NKG2A inhibitory receptors, and then bind HLA-E. Associations of certain KIR/HLA-C combinations with recurrent miscarriage, pre-eclampsia, and foetal growth restriction and the interactions between uNK cells, trophoblasts and vascular cells have led to the hypothesis that uNK cells may play a role in embryo implantation.
Datos de la publicación
- ISSN/ISSNe:
- 1355-4786, 1460-2369
- Tipo:
- Article
- Páginas:
- 720-746
- Factor de Impacto:
- 5,073 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
HUMAN REPRODUCTION UPDATE OXFORD UNIV PRESS
Citas Recibidas en Web of Science: 41
Documentos
- No hay documentos
Filiaciones
Keywords
- HLA-C, human pregnancy, immunotherapies, killer cell immunoglobulin-like receptors, materno–foetal interface, uterine natural killer cells
Proyectos asociados
Contrato Miguel Servet Tipo II - DOMINGUEZ HERNÁNDEZ, FRANCISCO
Investigador Principal: FRANCISCO DOMÍNGUEZ HERNÁNDEZ
MSII18/00002 . INSTITUTO DE SALUD CARLOS III . 2019
Contrato PFIS: Predoctorales de formación en investigación en salud. Andrea Palomar
Investigador Principal: FRANCISCO DOMÍNGUEZ HERNÁNDEZ
FI18/00009 . INSTITUTO DE SALUD CARLOS III . 2019
Influencia de los disruptores endocrinos sobre la receptividad endometrial humana y su relación con el fallo de impantación y la endometriosis.
Investigador Principal: FRANCISCO DOMÍNGUEZ HERNÁNDEZ
PI17/00931 . INSTITUTO DE SALUD CARLOS III . 2018
CARACTERIZACIÓN DEL ENVEJECIMIENTO OVÁRICO EN HUMANOS Y EN UN MODELO DE RATÓN DE SENESCENCIA OVÁRICA. ESTUDIO DE BIOMARCADORES DE RESERVA OVÁRICA
Investigador Principal: JUAN ANTONIO GARCÍA VELASCO
FPU18/02904 . MINISTERIO DE CIENCIA E INNOVACION . 2019
Perfiles transcriptómicos y secretómicos tras cultivo extendido de embriones humanos euploides y aneuploides para el cromosoma 21
Investigador Principal: FRANCISCO DOMÍNGUEZ HERNÁNDEZ
PI20/00405 . INSTITUTO DE SALUD CARLOS III . 2021
IMPACTO DE LA INFECCIÓN POR SARS-COV-2 (COVID-19) EN EL ENDOMETRIO HUMANO: EVALUACIÓN IN VITRO DE LOS EFECTOS DE HIDROXICLOROQUINA (HCQ) UTILIZANDO ORGANOIDES ENDOMETRIALES HUMANOS.
Investigador Principal: IRENE CERVELLÓ ALCARAZ
2020-268-1_CRC FERRING COVID_CERVELLO . FERRING PHARMACEUTICALS A/S . 2020
Cita
Díaz I,Alecsandru D,García JA,Domínguez F. Uterine natural killer cells: from foe to friend in reproduction. Hum Reprod Update. 2021. 27. (4):p. 720-746. IF:17,179. (1).